Compare MESO & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MESO | PLAB |
|---|---|---|
| Founded | 2004 | 1969 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2005 | 1995 |
| Metric | MESO | PLAB |
|---|---|---|
| Price | $13.68 | $28.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $37.00 | ★ $41.33 |
| AVG Volume (30 Days) | 255.3K | ★ 794.9K |
| Earning Date | 08-26-2026 | 12-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.09 |
| EPS | N/A | ★ 1.76 |
| Revenue | N/A | ★ $535,276,000.00 |
| Revenue This Year | $51.63 | $2.20 |
| Revenue Next Year | $63.39 | $2.81 |
| P/E Ratio | ★ N/A | $16.44 |
| Revenue Growth | N/A | ★ 18.77 |
| 52 Week Low | $11.89 | $20.05 |
| 52 Week High | $21.50 | $56.00 |
| Indicator | MESO | PLAB |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 52.25 |
| Support Level | $11.89 | $27.37 |
| Resistance Level | $16.03 | $29.89 |
| Average True Range (ATR) | 0.50 | 1.22 |
| MACD | 0.07 | 0.12 |
| Stochastic Oscillator | 40.72 | 82.14 |
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.
Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.